


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.57%
+0.62%
+3.33%
+3.39%
ROIV
Roivant Sciences Ltd.
$29.96

Login to see Roivant Sciences Ltd. (ROIV) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
ROIV Price Performance
$27.77 (+7.89%)
$28.94 (+3.52%)
$21.63 (+38.51%)
$11.09 (+170.15%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
ROIV Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ROIV Street Sentiment is extremely bullish and have negative views on the near-term outlook
ROIV has Fair risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Apr 30, 2026
Initiate
Buy
William Blair
Apr 23, 2026
Price Target Raised
Buy
Jefferies
Dec 16, 2025
Reiterate
Outperform
Leerink
ABUS
Arbutus Biopharma
4.35
-2.03%
PFE
Pfizer
25.90
-0.19%
EBS
Emergent Biosolution
8.45
+0.96%
EVO
Evotec SE
3.03
+1.68%
NVO
Novo Nordisk A/S
44.96
+1.33%
What is ROIV current stock price?
What is ROIV current Stock IQ?
What is ROIV RSI signal right now?
What is ROIV analyst price target and upside potential?
What do analysts say about ROIV stock?
What is ROIV momentum trend right now?
What are ROIV stock strengths?
What is ROIV Risk Level?
Should I buy ROIV stock right now?
Is ROIV a Strong Buy right now?
What is ROIV market cap and volume?
What factors influence ROIV's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ROIV
Roivant Sciences Ltd.
Current Price
$29.96
ABUS
Arbutus Biopharma
4.35
-2.03%
PFE
Pfizer
25.90
-0.19%
EBS
Emergent Biosolution
8.45
+0.96%
EVO
Evotec SE
3.03
+1.68%
NVO
Novo Nordisk A/S
44.96
+1.33%

ROIV Price Performance
$27.77 (+7.89%)
$28.94 (+3.52%)
$21.63 (+38.51%)
$11.09 (+170.15%)
ROIV Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
ROIV Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ROIV Street Sentiment is extremely bullish and have negative views on the near-term outlook
ROIV has Fair risk level

Overall Wall Street Rating
ROIV Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
ROIV Trading Signals
ROIV is showing high volatility with an intraday swing of 6.27% (High: $32.71, Low: $30.78). This signals potential risk.
ROIV has negative earnings news: Weak Earnings. Earnings Scheduled For May 20 2026. Companies Reporting Before The Bell . GDS Holdings (NASDAQ: GDS ) is likely to report quarterly earnings at $1....
ROIV has positive earnings news: Beat Estimates. TAT Technologies Posts Upbeat Q1 Earnings Joins Roivant Sciences Immunitybio And Other Big Stocks Moving Higher On Wednesday. United States stocks we...
ROIV has positive earnings news: Strong Earnings. Roivant Sciences Reports Q4 2026 Results: Full Earnings Call Transcript. Roivant Sciences (NASDAQ: ROIV ) reported fourth-quarter financial results o...
ROIV has positive earnings news: Beat Estimates. Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2025 Earnings Call Transcript. Roivant Sciences Ltd. (NASDAQ: ROIV ) Q4 2025 Earnings Call Transcript May 20 20...
ROIV beat earnings expectations. TAT Technologies Posts Upbeat Q1 Earnings Joins Roivant Sciences Immunitybio And Other Big Stocks Moving Higher On Wednesday. United States stocks we...
ROIV beat earnings expectations. Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2025 Earnings Call Transcript. Roivant Sciences Ltd. (NASDAQ: ROIV ) Q4 2025 Earnings Call Transcript May 20 20...
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ROIV Stock trends
ROIV Stock performance
ROIV Stock analysis
ROIV investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.